Amylx Pharmaceuticals Inc vs Chipotle Mexican Grill, Inc. — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Chipotle Mexican Grill, Inc. trades at $32.69 (market cap $40.49B). The key difference: Chipotle Mexican Grill, Inc. is far larger — about 15.3× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Chipotle Mexican Grill, Inc. nearer its low. Which is the better fit depends on your goals.
| AMLX | CMG | |
|---|---|---|
Market Cap | $2.64B | $40.49B |
Sector | Health | Consumer Cyclical |
52-Week High | $24.19 | $44.04 |
52-Week Low | $7.82 | $28.17 |
Enterprise Value | $2.39B | $45.24B |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Chipotle Mexican Grill is the largest fast-casual chain restaurant in the United States, with systemwide sales of $7.5 billion in 2021. The Mexican concept is entirely company-owned, with a footprint of more than 3,000 stores, heavily indexed to the United States (though the firm maintains a small presence in Canada, the U.K., France, and Germany). Chipotle sells burritos, burrito bowls, tacos, quesadillas, and beverages, with a selling proposition built around competitive prices, high-quality food sourcing, speed of service, and convenience. The company generates its revenue entirely from restaurant sales and delivery fees.
Read more on CMG →